| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 9 |
| 1 | METHOTREXATE SODIUM | 9 |
| 2 | PEMIGATINIB | 9 |
| 3 | CAPECITABINE | 8 |
| 4 | METHOTREXATE | 8 |
| 5 | ADALIMUMAB | 6 |
| 6 | ADALIMUMAB-AATY | 6 |
| 7 | ADALIMUMAB-ADAZ | 6 |
| 8 | ADALIMUMAB-FKJP | 6 |
| 9 | APREMILAST | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEMIGATINIB | 9 | 0.0106 |
| 1 | LAROTRECTINIB | 2 | 0.0022 |
| 2 | RITUXIMAB-ABBS | 2 | 0.0004 |
| 3 | VINORELBINE | 1 | 0.0001 |
| 4 | ADALIMUMAB-FKJP | 6 | 0.0001 |
| 5 | ADALIMUMAB-AATY | 6 | 0.0001 |
| 6 | ADALIMUMAB-ADAZ | 6 | 0.0001 |
| 7 | CAPECITABINE | 8 | 0.0001 |
| 8 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 1 | 0.0001 |
| 9 | CRIZOTINIB | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 1 | 0.0000 |
| 1 | Phosphodiesterase 4 Inhibitor [EPC] | 6 | 0.0000 |
| 2 | Platinum-based Drug [EPC] | 9 | 0.0000 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 8 | 0.0000 |
| 4 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 5 | Aminoglycoside Antibacterial [EPC] | 1 | 0.0000 |
| 6 | Kinase Inhibitor [EPC] | 12 | 0.0000 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 8 | 0.0000 |
| 8 | Proteasome Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Androgen Receptor Inhibitor [EPC] | 1 | 0.0000 |